Antimalarial drug toxicity: a review.

Antimalarial drug toxicity: a review.

Malaria, caused mostly by Plasmodium falciparum and P. vivax, remains one of the most important infectious diseases in the world. Antimalarial drug toxicity is one side of the risk-benefit equation and is viewed differently depending upon whether the clinical indication for drug administration is ma...

Bibliografski detalji
Glavni autori:	Taylor, W, White, N
Format:	Journal article
Jezik:	English
Izdano:	2004

Slični predmeti

Toxicity of antimalarial drugs.
od: Peto, T
Izdano: (1989)

The cardiovascular toxicity of antimalarial drugs
od: Chan, XHS
Izdano: (2019)

Antimalarial drug and renal toxicity
od: Wiwanitkit Viroj
Izdano: (2016-01-01)

Antimalarial drug resistance
od: White, N
Izdano: (2004)

Antimalarial drug resistance.
od: White, N
Izdano: (2004)

Cardiotoxicity of antimalarial drugs.
od: White, N
Izdano: (2007)

The assessment of antimalarial drug efficacy.
od: White, N
Izdano: (2002)

Clinical pharmacokinetics of antimalarial drugs.
od: White, N
Izdano: (1985)

The threat of antimalarial drug resistance
od: Hanboonkunupakarn, B, i dr.
Izdano: (2016)

Retinal toxicity induced by antimalarial drugs: literature review and case report
od: Manuel Garza-Leon, i dr.
Izdano: (2016-06-01)

Antimalarial herbal drugs: a review of their interactions with conventional antimalarial drugs
od: Earnest Oghenesuvwe Erhirhie, i dr.
Izdano: (2021-01-01)

Antimalarial drug resistance: the pace quickens.
od: White, N
Izdano: (1992)

Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
od: Barnes, K, i dr.
Izdano: (2005)

How do patients use antimalarial drugs? A review of the evidence.
od: Yeung, S, i dr.
Izdano: (2005)

Mode of action and features of antimalarial drugs
od: Nosten, F, i dr.
Izdano: (1999)

Mode of action and features of antimalarial drugs.
od: Nosten, F, i dr.
Izdano: (1999)

Delaying antimalarial drug resistance with combination chemotherapy.
od: White, N
Izdano: (1999)

Assessment of the pharmacodynamic properties of antimalarial drugs in vivo.
od: White, N
Izdano: (1997)

Preventing antimalarial drug resistance through combinations.
od: White, N
Izdano: (1998)

Antimalarial dosing regimens and drug resistance.
od: Barnes, K, i dr.
Izdano: (2008)

The assessment of antimalarial drug efficacy in vivo
od: White, NJ
Izdano: (2022)

Retinal toxicity to antimalarial drugs: chloroquine and hydroxychloroquine: a neurophysiologic study
od: Farrell DF
Izdano: (2012-03-01)

Why is it that antimalarial drug treatments do not always work?
od: White, N
Izdano: (1998)

Antimalarial drugs in pregnancy: a review.
od: Nosten, F, i dr.
Izdano: (2006)

Hypoglycaemia and antimalarial drugs: quinidine and release of insulin.
od: Phillips, R, i dr.
Izdano: (1986)

Monitoring antimalarial drug efficacy - Reply
od: Mayxay, M, i dr.
Izdano: (2004)

Pharmacokinetic determinants of the window of selection for antimalarial drug resistance.
od: Stepniewska, K, i dr.
Izdano: (2008)

The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review
od: Haeusler, I, i dr.
Izdano: (2018)

World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs.
od: Price, R, i dr.
Izdano: (2007)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
od: Price, R, i dr.
Izdano: (2007)

How antimalarial drug resistance affects post-treatment prophylaxis.
od: White, N
Izdano: (2008)

Antimalarial mass drug administration: ethical considerations
od: Cheah, PY, i dr.
Izdano: (2016)

Abnormal circulatory control in falciparum malaria: the effects of antimalarial drugs.
od: Supanaranond, W, i dr.
Izdano: (1993)

Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria.
od: Pukrittayakamee, S, i dr.
Izdano: (2004)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
od: Olliaro Piero, i dr.
Izdano: (2007-09-01)

A systematic overview of published antimalarial drug trials.
od: Myint, H, i dr.
Izdano: (2004)

Enantiospecific pharmacokinetics and drug-drug interactions of primaquine and blood-stage antimalarial drugs
od: Chairat, K, i dr.
Izdano: (2018)

Antimalarial Drug Resistance and Novel Targets for Antimalarial Drug Discovery
od: Shibeshi MA, i dr.
Izdano: (2020-11-01)

Does antimalarial mass drug administration increase or decrease the risk of resistance?
od: White, N
Izdano: (2016)

Effectiveness of antimalarial drugs.
od: Baird, J
Izdano: (2005)